Ken Griffin Haleon PLC Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Haleon PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 110,100 shares of HLN stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

110,100

Previous 20,200 445.05%

Holding current value

$1.09 Million

Previous $213,000 393.9%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$9.23 - $10.71 $45.2 Million - $52.5 Million	4,901,017 Added 406.87%	6,105,593 $58.4 Million
Q3 2024 Nov 14, 2024	SELL	$8.32 - $10.7 $37 Million - $47.6 Million	-4,446,565 Reduced 78.68%	1,204,576 $12.7 Million
Q2 2024 Aug 14, 2024	SELL	$8.01 - $8.64 $60.1 Million - $64.8 Million	-7,504,868 Reduced 57.05%	5,651,141 $46.7 Million
Q1 2024 May 15, 2024	BUY	$8.02 - $8.67 $102 Million - $110 Million	12,670,564 Added 2610.09%	13,156,009 $112 Million
Q4 2023 Feb 14, 2024	BUY	$7.78 - $8.62 $918,926 - $1.02 Million	118,114 Added 32.15%	485,445 $4 Million
Q3 2023 Nov 14, 2023	BUY	$7.85 - $8.94 $2.86 Million - $3.25 Million	363,985 Added 10878.21%	367,331 $3.06 Million
Q2 2023 Aug 14, 2023	SELL	$8.04 - $9.0 $566,426 - $634,059	-70,451 Reduced 95.47%	3,346 $28,000
Q1 2023 May 15, 2023	SELL	$7.57 - $8.37 $6.61 Million - $7.31 Million	-873,733 Reduced 92.21%	73,797 $600,000
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.06 $4.68 Million - $6.33 Million	785,976 Added 486.51%	947,530 $7.58 Million
Q3 2022 Nov 14, 2022	BUY	$5.63 - $7.5 $909,549 - $1.21 Million	161,554 New	161,554 $984,000

Others Institutions Holding HLN

# of Institutions

659

Shares Held

432M

Call Options Held

269K

Put Options Held

40.6K

View Full List

About Haleon plc

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $45.7B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

More about HLN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account